Uploaded August 2023 | Updated November 2026, 5 days ago
ChromoSeq is the name of a new test for two blood cancers – a test developed by a team at Washington University School of Medicine in St. Louis. ChromoSeq is the first whole-genome sequencing test for cancer to be approved for reimbursement by the Centers for Medicare & Medicaid Services. For more information, see here: https://medicine.wustl.edu/news/medicare-approves-washu-medicines-whole-genome-test-for-blood-cancers/
Video by Katie Gertler/Washington University School of Medicine in St. Louis
ChromoSeq is the name of a new test for two blood cancers – a test developed by a team at Washington University School of Medicine in St. Louis. ChromoSeq is the first whole-genome sequencing test for cancer to be approved for reimbursement by the Centers for Medicare & Medicaid Services. For more information, see here: https://medicine.wustl.edu/news/medicare-approves-washu-medicines-whole-genome-test-for-blood-cancers/
Video by Katie Gertler/Washington University School of Medicine in St. Louis










